Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
21.60
+0.10 (0.47%)
At close: Mar 6, 2026

Vistin Pharma ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
74.7662.7545.6-4.7224.87
Upgrade
Depreciation & Amortization
22.5319.0317.3512.2810.61
Upgrade
Other Operating Activities
21.0817.712.92-1.297.13
Upgrade
Change in Accounts Receivable
--3.1212.14-20.81-12.76
Upgrade
Change in Inventory
-3.513.28-40.54-11.12
Upgrade
Change in Other Net Operating Assets
-39.667.99-0.6944.57-5.05
Upgrade
Operating Cash Flow
78.71107.8690.59-10.5113.68
Upgrade
Operating Cash Flow Growth
-27.02%19.06%---
Upgrade
Capital Expenditures
-16.68-40.8-17.9-64.29-31.94
Upgrade
Other Investing Activities
-0.510.220.030.27
Upgrade
Investing Cash Flow
-16.68-40.3-17.68-64.26-31.68
Upgrade
Short-Term Debt Issued
---45.14-
Upgrade
Total Debt Issued
---45.14-
Upgrade
Short-Term Debt Repaid
---45.14--
Upgrade
Long-Term Debt Repaid
--1.2-0.9-2.59-0.84
Upgrade
Total Debt Repaid
--1.2-46.05-2.59-0.84
Upgrade
Net Debt Issued (Repaid)
--1.2-46.0542.55-0.84
Upgrade
Common Dividends Paid
-55.43-77.59---22.17
Upgrade
Other Financing Activities
-2.97-2.19-2.1-2.09-0.29
Upgrade
Financing Cash Flow
-58.4-80.97-48.1440.46-23.3
Upgrade
Miscellaneous Cash Flow Adjustments
--0000
Upgrade
Net Cash Flow
3.63-13.4124.77-34.31-41.29
Upgrade
Free Cash Flow
62.0367.0572.69-74.8-18.26
Upgrade
Free Cash Flow Growth
-7.49%-7.75%---
Upgrade
Free Cash Flow Margin
13.71%15.61%16.58%-24.54%-6.55%
Upgrade
Free Cash Flow Per Share
1.401.511.64-1.69-0.41
Upgrade
Cash Interest Paid
-2.192.12.090.29
Upgrade
Levered Free Cash Flow
14.1136.7554.19-81.62-30.41
Upgrade
Unlevered Free Cash Flow
20.9938.2155.61-80.28-30.19
Upgrade
Change in Working Capital
-39.668.3814.73-16.78-28.92
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.